Order MDAI Research Chemical USA
MDAI (5,6-methylenedioxy-2-aminoindane) is a novel, non-neurotoxic and highly selective serotonin-releasing agent (SSRA) in vitro with the potential for use as an antidepressant. MDAI was developed at the National Institute of Mental Health by a team from Purdue University under the supervision of David E. Nichols.
MDAI is a synthetic indoleamine that acts as a selective serotonin-releasing agent (SSRA) in vitro and produces psychedelic effects in humans. MDAI is known to produce entactogenic effects in human volunteers.
MDAI is a synthetic substance chemically related to other psychedelic drugs like LSD and psilocybin.
MDMA is a synthetic drug that acts as an empathogen, producing feelings of empathy and emotional closeness to others. It also produces entactogenic effects.
MDMA (3,4-methylenedioxymethamphetamine) is the salt form of a synthetic compound. X}
MDAI (5,6-methylenedioxy-2-aminoindane) is a highly potent and selective serotonin reuptake inhibitor (SSRI) that acts as a non-neurotoxic and highly selective serotonin-releasing agent (SSRA) in vitro. Results of animal studies indicate that MDAI may be effective in treating anxiety disorders as well as depression and obsessive-compulsive disorder.
MDAI (5,6-methylenedioxy-2-aminoindane) is a novel, selective serotonin reuptake inhibitor (SSRI) and selective serotonin releasing agent (SSRA), which acts as a non-neurotoxic and highly selective serotonin uptake inhibitor (SSRI) at low doses. Results of animal studies have indicated that MDAI may be a potentially effective pharmacological agent in the treatment of anxiety disorders as well as depression, obsessive-compulsive disorder, sleep disorders, and weight control. This compound has demonstrated superior efficacy to traditional SSRIs such as fluoxetine and sertraline in animal studies, indicating that it may possess fewer side effects than existing antidepressants.
MDAI (5,6-methylenedioxy-2-aminoindane) is a powerful, fast-acting drug with potent anti-depressant and anti-anxiety qualities. It might be useful in treating depression, OCD, PTSD and other psychiatric disorders.
A serotonin reuptake inhibitor (commonly known as an SSRI) is a drug that increases extracellular levels of the neurotransmitter serotonin by inhibiting its reuptake into the presynaptic cell. Contrary to popular belief, the “S” in SSRI does not stand for “serotonin” but for “selective.”
The compound acts as a serotonin reuptake inhibitor, and it is highly potent.
MDAI 5,6-methylenedioxy-2-aminoindane is a high-affinity serotonin-releasing agent (HASRA) in vitro but produces opposite effects in vivo. MDAI is a selective serotonin reuptake inhibitor with moderate affinity for the serotonin transporter (SERT).
MDAI (5,6-methylenedioxy-2-aminoindane) is a drug developed in the 1990s by a team led by David E. Nichols at Purdue University. It acts as a non-neurotoxic and highly selective serotonin-releasing agent (SSRA) in vitro and produces entactogen effects in humans at low doses but does not have a dopamine release effect like most other hallucinogens.
MDAI is an entactogen that produces serotonin-mediated entactogenesis effects. MDAI has been used as a substitute for MDMA to avoid the neurotoxicity and dangers associated with MDMA abuse.
Why Buy MDAI online From Us?
We are a long established and trusted supplier of Research Chemicals
Best RC Vendor online
Our RC are of high purity 99.9%
We provide shipping Tracking Number once parcel is shipped.
Our customers leave genuine reviews which allow you to buy with confidence
Everest Chemicals makes it possible for you to access the best quality research chemicals , Psychedelics, Cannabinoids ,Empathogens and more. We ship allover USA, UK, Europe, Australia, Canada and Asia .